Daily Archives: November 28, 2019 | LinksMedicus Free Medical News & Perspectives

Thu November 28 – 10 Stories of The Day!

28 Nov, 2019 | 10:51h | UTC

1 – Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Diagnosis of Pulmonary Embolism – American College of Cardiology (free)

2 – Aupplemental MRI Screening for Women with Extremely Dense Breast Tissue – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Does MRI Screening Benefit Women With Extremely Dense Breasts? – U.S. News (free) AND Mixed Results With Mammo Plus MRI Screening – MedPage Today (free)

“The benefits need to be carefully weighed against the harms, as MRI examination is more expensive, and it requires the injection of a contrast agent into the body. MRI will also detect abnormalities that later turn out not to be breast cancer after all” (from U.S News)

3 – Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Head-to-head comparison finds three anti-seizure drugs equally effective for severe form of epilepsy – NIH News Release (free)

4 – Association Between Physician Depressive Symptoms and Medical Errors: A Systematic Review and Meta-analysis – JAMA Network Open (free)

Commentary: Depression in Docs Leads to Medical Errors and Vice Versa – Medscape (free registration required)

5 – Consolidated guidelines on HIV testing services for a changing epidemic – World Health Organization (free)

Commentaries: WHO Releases New HIV Testing Guidelines To Help Expand Treatment Coverage, Reduce HIV Transmission – Health Policy Watch (free) AND WHO releases new HIV testing guidelines – Global ID News (free)

6 – Updated international consensus report on the investigation and management of primary immune thrombocytopenia – Blood Advances (free)

7 – What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD – U.S. Food & Drug Administration (free)

Commentaries: FDA’s Warning On CBD: Cannabis Stocks Drop, Companies Object – Forbes (free) AND ‘CBD has the potential to harm you,’ FDA warns consumers – MarketWatch (free)

Related: Cannabidiol Products Are Everywhere, but Should People Be Using Them? – JAMA (free for a limited period) AND NICE Guideline: Cannabis-Based Medicinal Products (free Guideline and other resources)

8 – What Are the Benefits of Probiotics? – The New York Times (free)

Related: Systematic Review: Harms Reporting in Trials with Probiotics (link to abstract and commentaries) AND The Problem With Probiotics – The New York Times (free)

9 – News Release: Antibiotic-Resistant Bacteria More Prevalent in Device-Related Infections – Society for Healthcare Epidemiology of America (free)

Original Studies: Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017 – Infection Control & Hospital Epidemiology (free) AND Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017 – Infection Control & Hospital Epidemiology (free)

Commentary: CDC: Medical devices key source of antibiotic-resistant infections – CIDRAP (free)

10 – Associations of dairy intake with risk of mortality in women and men: three prospective cohort studies – The BMJ (free)

[Abstract Only] Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

28 Nov, 2019 | 10:36h | UTC

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Head-to-head comparison finds three anti-seizure drugs equally effective for severe form of epilepsy – NIH News Release (free)

Related Commentary on Twitter

Intravenous valproate, levetiracetam, and fosphenytoin stopped status epilepticus that was resistant to initial treatment with lorazepam in approximately half the patients and did not differ significantly in effectiveness. https://t.co/RfO7YKEoue

— NEJM (@NEJM) November 28, 2019

[Abstract Only] Randomized Trial: Supplemental MRI Screening vs. Usual Care with Mammography Only for Women with Extremely Dense Breast Tissue

28 Nov, 2019 | 10:39h | UTC

Supplemental MRI Screening for Women with Extremely Dense Breast Tissue – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Does MRI Screening Benefit Women With Extremely Dense Breasts? – U.S. News (free) AND Mixed Results With Mammo Plus MRI Screening – MedPage Today (free)

Related Commentary on Twitter

In this randomized trial, women with extremely dense breast tissue were invited to undergo MRI screening or received only mammography during a 2-year screening period. https://t.co/tZmcappO00

— NEJM (@NEJM) November 27, 2019